Immix Biopharma Investor Presentation Deck

N-GENIUS Technology Platform – Proprietary COBRA Binding Domain Is a Differentiated Innovation Abecma 4-11 CD32 Carvykti 4-1BB CD3( Note: Graphic representation. COBRA = Codon Optimized Binder for Receptor Antigens - Proprietary Binding Domain CART- ddBCMA 4-1BB CD3( NXC-201 with COBRA Binding Domain 4-1BBY CD32Y N-GENIUS EXPAND Technology ●●● S IMMIX BIOPHARMA 15

View entire presentation